PetMed Express (NASDAQ:PETS) Downgraded to Hold Rating by StockNews.com

PetMed Express (NASDAQ:PETS) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.

PetMed Express Stock Down 14.0 %

NASDAQ:PETS traded down $0.74 during trading hours on Tuesday, hitting $4.53. 1,237,535 shares of the company’s stock traded hands, compared to its average volume of 271,535. The firm has a market cap of $93.59 million, a P/E ratio of -75.50 and a beta of 0.70. PetMed Express has a 52 week low of $2.90 and a 52 week high of $6.85. The business’s fifty day simple moving average is $5.15 and its two-hundred day simple moving average is $4.32.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.02). PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, analysts expect that PetMed Express will post 0.24 EPS for the current year.

Insiders Place Their Bets

In other news, Director Leslie C.G. Campbell purchased 15,000 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was purchased at an average price of $5.38 per share, with a total value of $80,700.00. Following the completion of the purchase, the director now directly owns 70,000 shares in the company, valued at approximately $376,600. This trade represents a 27.27 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Independent Advisor Alliance purchased a new position in PetMed Express during the 3rd quarter valued at about $106,000. Bleakley Financial Group LLC purchased a new position in PetMed Express during the 3rd quarter valued at about $279,000. R Squared Ltd purchased a new position in PetMed Express during the 4th quarter valued at about $31,000. American Century Companies Inc. increased its holdings in PetMed Express by 15.3% during the 4th quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock valued at $162,000 after purchasing an additional 4,459 shares during the period. Finally, Virtu Financial LLC purchased a new position in PetMed Express during the 4th quarter valued at about $58,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.